Tratamentul hepatitelor cronice virale B, C şi D cu preparatele entomologice IMUHEPTIN  şi IMUPURIN
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
729 6
Ultima descărcare din IBN:
2021-05-05 18:34
Căutarea după subiecte
similare conform CZU
616.36-002.2-085+615.37+595.7 (1)
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1732)
Medicamentele potrivit originii lor (478)
Articulata (347)
SM ISO690:2012
PÂNTEA, Victor, SMEŞNOI, Valentina, CIUHRII, Veaceslav, CORNEA, Natalia, TOFAN, Valentin. Tratamentul hepatitelor cronice virale B, C şi D cu preparatele entomologice IMUHEPTIN  şi IMUPURIN. In: Sănătate Publică, Economie şi Management în Medicină , 2017, nr. 3(73), pp. 152-154. ISSN 1729-8687.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Sănătate Publică, Economie şi Management în Medicină
Numărul 3(73) / 2017 / ISSN 1729-8687 /ISSNe 2587-3873

Tratamentul hepatitelor cronice virale B, C şi D cu preparatele entomologice IMUHEPTIN  şi IMUPURIN

Chronic viral hepatitis B, C and D treatment with entomological drugs IMUHEPTIN and IMUPURIN

CZU: 616.36-002.2-085+615.37+595.7

Pag. 152-154

Pântea Victor1, Smeşnoi Valentina2, Ciuhrii Veaceslav3, Cornea Natalia3, Tofan Valentin3
 
1 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
2 Spitalul Clinic Republican de Boli Infecţioase „Toma Ciorbă“,
3 Newtone Laboratories SRL
 
 
Disponibil în IBN: 3 noiembrie 2017


Rezumat

The evolution of clinical, biochemical and immunological parameters in patients with chronic viral hepatitis under the influence of treatment with Imuheptin and Imupurin was examinated. After 3 months of treatment complete regression or decrease of following clinical signs and syndroms: dyspepsic and astenovegetativ syndroms, hepatomegaly, splenomegaly and artralgy was found. Results of laboratory investigations confi rmed the positive evolution of clinical signs. Decrease of ALT and AST activity in all monitored patients and decrease of thymol test level were found. Immunomodulating effect consisting in increase of the CD4 + - and CD3 + lymphocytes and decrease of the CD20 + -lymphocytes and CIC was found. All patients showed good tolerability of the administered medication during the study..